Monash Health to expand Evusheld availability to the community

To support the health and wellbeing of the community, Monash Health continues to do everything it can to protect people from COVID-19.

Since delivering the first COVID-19 vaccination in Victoria in February 2021, Monash Health’s South East Public Health Unit vaccination clinics have delivered almost 1.5 million COVID-19 vaccines to the community.

Since October 2021, Monash Health’s Early COVID Therapies clinic has also provided over 600 treatments to those affected by COVID-19 to assist their recovery and prevent hospitalisation.

Now, Monash Health is providing eligible patients with Evusheld: a long-acting antibody combination (tixagevimab/cilgavimab) medication which is used for prevention of COVID-19 in high-risk patients.

While vaccination is the best protection against COVID-19, Evusheld may be appropriate for people who cannot receive vaccines or are less likely to be protected by them such as those who are immunosuppressed. More information on Evusheld is available here.

To best protect those most at risk from COVID-19, Monash Health will expand its Evusheld clinic with four additional clinics in July 2022. With community transmission of COVID-19 expected to remain high in the winter months, everyone who is eligible for Evusheld is strongly encouraged to visit a Monash Health clinic to receive the medication.

More information to come on how to book an Evusheld appointment soon.